Exact(2)
The potential of a recombination event resulting in a single VSV vector virus expressing both these NiV proteins is unlikely, but it may still be problematic for a human use vaccine.
Future studies should seek to use vaccine vectors that increase the magnitude and quality of the IFN-γ immune response in naturally exposed populations and should monitor the induction of a regulatory T cell response.
Similar(57)
But while Canada and some European nations will use vaccines containing adjuvants, American officials have decided against it for now.
Most European countries and Canada use vaccines with adjuvants, which are usually mixtures of water and oil that, for unknown reasons, increase the immune response and make smaller doses of vaccine work better.
The same approach is being evaluated for human use vaccines, mainly for the prevention of HIV and AIDS [27].
The same approach for human use vaccines is undergoing extensive evaluation, largely for HIV and AIDS [27].
For the induction of robust humoral and cellular immune responses, a strong rationale exists to use vaccine-adjuvant combinations possessing both immune modulatory and enhanced delivery capabilities.
One explanation for this result is failure to use vaccines.
We will use "vaccines" to refer to generic immune intervention and will use terms "therapeutic vaccines" and "prophylactic vaccines" to distinguish between the two modalities.
Use vaccines.
During the 2009 influenza pandemic in Sweden vaccination was performed using vaccine containing the AS03 system [ 2].
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com